Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
ISPAGHULA HUSKS
Reckitt Benckiser Ireland Ltd
3.5 Grams
Granules Effervescent
2001-09-21
IRISH MEDICINES BOARD ACT 1995 MEDICINAL PRODUCTS(LICENSING AND SALE)REGULATIONS, 1998 (S.I. NO.142 OF 1998) PA0979/009/003 Case No: 2032524 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to RECKITT BENCKISER IRELAND LTD 7 RIVERWALK, CITYWEST BUSINESS CAMPUS, DUBLIN 24, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product FYBOGEL LEMON 3.5G EFFERVESCENT GRANULES The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 06/02/2007. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 13/04/2007_ _CRN 2032524_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Fybogel Lemon 3.5g Effervescent Granules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains 3.5g ispaghula husk. Also contains 16mg aspartame, per sachet. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Effervescent granules Orange to buff-coloured granules with a lemon odour. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Clinical Indication: for the treatment of patients requiring a high fibre regimen. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Fybogel Lemon is intended for oral administration in a suspension in a drink of water. The granules should be stirred into a glass of water an Read the complete document